Search Results - "Jani, Prashant"

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone by Rakovitch, Eileen, Nofech-Mozes, Sharon, Hanna, Wedad, Baehner, Frederick L., Saskin, Refik, Butler, Steven M., Tuck, Alan, Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A., Bonin, Michel, Chang, Martin C., Robertson, Susan J., Slodkowska, Elzbieta, Fong, Cindy, Anderson, Joseph M., Jamshidian, Farid, Miller, Dave P., Cherbavaz, Diana B., Shak, Steven, Paszat, Lawrence

“…Validated biomarkers are needed to improve risk assessment and treatment decision-making for women with ductal carcinoma in situ (DCIS) of the breast. The Onco…”
Get full text

Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ by Rakovitch, Eileen, Nofech-Mozes, Sharon, Hanna, Wedad, Sutradhar, Rinku, Baehner, Frederick L, Miller, Dave P, Fong, Cindy, Gu, Sumei, Tuck, Alan, Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A, Bonin, Michel, Chang, Martin C, Slodkowska, Elzbieta, Anderson, Joseph M, Cherbavaz, Diana B, Shak, Steven, Paszat, Lawrence

“…Most women with ductal carcinoma in situ (DCIS) will receive breast-conserving surgery (BCS) and radiation (RT). RT can be omitted for women at low risk of…”
Get full text

Long-term Outcomes of Hypofractionation Versus Conventional Radiation Therapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ of the Breast by Lalani, Nafisha, MD, Paszat, Lawrence, MD, FRCPC, Sutradhar, Rinku, PhD, Thiruchelvam, Deva, MSc, Nofech-Mozes, Sharon, MD, FRCPC, Hanna, Wedad, MD, FRCPC, Slodkowska, Elzbieta, MD, FRCPC, Done, Susan J., MB, FRCPC, Miller, Naomi, MD, FRCPC, Youngson, Bruce, MD, FRCPC, Tuck, Alan, MD, FRCPC, Sengupta, Sandip, MD, FRCPC, Elavathil, Leela, MD, FRCPC, Chang, Martin C., MD, PhD, FCAP, FRCPC, Jani, Prashant A., MD, FCAP, FRCPC, Bonin, Michel, MD, FRCPC, Rakovitch, Eileen, MD, FRCPC

“…Purpose Whole-breast radiation therapy (XRT) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) may decrease the risk of local…”
Get full text

Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis by Rakovitch, Eileen, Nofech-Mozes, Sharon, Narod, Steven A., Hanna, Wedad, Thiruchelvam, Deva, Saskin, Refik, Taylor, Carole, Tuck, Alan, Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A., Done, Susan J., Miller, Naomi, Youngson, Bruce, Kong, Iwa, Paszat, Lawrence

“…Ductal carcinoma in situ (DCIS), a non-invasive breast cancer, is usually treated by breast-conserving surgery (BCS). Randomized trials prove that the addition…”
Get full text

Leptomeningeal Carcinomatosis Associated with Gall Bladder Carcinoma: a Case Report and Review of Literature by Khan, Talal H., Veer, Manik, Bilal, Mohammad, Curran-Melendez, Sheilah, Jani, Prashant M., Long, Gregory S.

Get full text

Impact of Boost Radiation in the Treatment of Ductal Carcinoma In Situ: A Population-Based Analysis by Rakovitch, Eileen, MD, FRCPC, Narod, Steven A., MD, FRCPC, Nofech-Moses, Sharon, MD, FRCPC, Hanna, Wedad, MD, FRCPC, Thiruchelvam, Deva, MSc, Saskin, Refik, MSc, Taylor, Carole, MSc, Tuck, Alan, MD, FRCPC, Youngson, Bruce, MD, FRCPC, Miller, Naomi, MD, FRCPC, Done, Susan J., MB, BChir, PhD, FRCPC, Sengupta, Sandip, MD, FRCPC, Elavathil, Leela, MD, FRCPC, Jani, Prashant A., MD, FCAP, FRCPC, Bonin, Michel, MD, FRCPC, Metcalfe, Stephanie, MSc, Paszat, Lawrence, MD, FRCPC

“…Purpose To report the outcomes of a population of women with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery and radiation and to…”
Get full text

Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy by Rakovitch, Eileen, Nofech-Mozes, Sharon, Hanna, Wedad, Sutradhar, Rinku, Gu, Sumei, Fong, Cindy, Tuck, Alan, Youngson, Bruce, Miller, Naomi, Done, Susan J., Chang, Martin C., Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A., Bonin, Michel, Lalani, Nafisha, Paszat, Lawrence

“…Radiation therapy (RT) after breast-conserving surgery (BCS) for Ductal Carcinoma in Situ (DCIS) halves the risk of local recurrence (LR). The omission of RT…”
Get full text

Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysis by Klein, Jonathan, Kong, Iwa, Paszat, Lawrence, Nofech-Mozes, Sharon, Hanna, Wedad, Thiruchelvam, Deva, Narod, Steven A., Saskin, Refik, Done, Susan J., Miller, Naomi, Youngson, Bruce, Tuck, Alan, Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A., Slodkowska, Elzbieta, Bonin, Michel, Rakovitch, Eileen

“…Mastectomy is effective treatment for ductal carcinoma in situ (DCIS) but some women will develop chest wall recurrence. Most chest wall recurrences that…”
Get full text

In Vivo 3T Magnetic Resonance Imaging Using a Biologically Specific Contrast Agent for Prostate Cancer: A Nude Mouse Model by Zehbe, Ingeborg, Campbell, Michael, Turuba, Roxanne, Jani, Prashant, Abraham, Christopher Brian, Curiel, L.

“…We characterized in vivo a functional superparamagnetic iron-oxide magnetic resonance contrast agent that shortens the T2 relaxation time in magnetic resonance…”
Get full text

Factors Influencing Tolerance to Total Body Irradiation (400 cGy) for Hematopoietic Stem Cell Transplantation by Mewawalla, Prerna, M.D, Guerrieri, Patrizia, M.D, Jani, Prashant, M.D, Sahovic, Entezam A., M.D, Lister, John, M.D

Get full text

Tumor Microenvironment before and after Chemoradiation in Locally Advanced Rectal Cancer: Beyond PD-L1 by Tayshetye, Pritam, Friday, Andrew J, Omstead, Ashten N, Verma, Tanvi, Miller, Stacey, Zheng, Ping, Jani, Prashant, Zaidi, Ali, Finley, Gene

“…In locally advanced rectal cancer treatment, neoadjuvant concurrent chemoradiation therapy (cCRT) is the standard of care. The tumor microenvironment (TME) is…”
Get full text

Do immune-related adverse effects predict better outcomes in lung cancer? by Jani, Prashant Mukesh, Sandhu, Ariel, Kamran, Amir, Pasricha, Gurleen, Patibandla, Sai Krishna, Yellala, Amulya, Tang, Amy, Finley, Gene Grant

“…Abstract only…”
Get full text

All-trans retinoic acid + arsenic trioxide versus other regimens for the treatment of acute promyelocytic leukemia: A single institution experience by Tayshetye, Pritam, Jani, Prashant Mukesh, Lee, Daniel Jung, Sadashiv, Santhosh K., Fazal, Salman, Khan, Cyrus, Mewawalla, Prerna, Koget, Anna, Berteotti, Gina, Tang, Amy, Lister, John

“…Abstract only…”
Get full text

Effect of neoadjuvant chemoradiation on the tumor microenvironment in rectal cancer by Jani, Prashant Mukesh, Renz, Paul, Brem, Candice, Abel, Stephen, Raj, Moses S., Monga, Dulabh K., McCormick, James, Silverman, Jan F, Kirichenko, Alexander V., Finley, Gene Grant

“…Abstract only e15115 Background: Chemoradiotherapy (CRT) followed by surgery is standard treatment for most rectal cancers. This creates an inflammatory…”
Get full text

Alteration of immune markers in the tumor microenvironment after chemoradiation for rectal cancer by Jani, Prashant Mukesh, Renz, Paul, Brem, Candice, Hasan, Shaakir, Sandhu, Ariel, Joseph, Paul, Zaidi, Ali Hussainy, McCormick, James, Kirichenko, Alexander V., Miller, Stacey, Raj, Moses S., Silverman, Jan F, Finley, Gene Grant

“…Abstract only…”
Get full text

Biomarkers of immunotherapy response in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy by Kaur, Gurveen, Tayshetye, Pritam, Jani, Prashant Mukesh, Omstead, Ashten N, Renz, Paul, Brem, Candice, Hasan, Shaakir, Sandhu, Ariel, Joseph, Paul, Babar, Laila, Zheng, Ping, Zaidi, Ali Hussainy, McCormick, James, Kirichenko, Alexander V., Miller, Stacey, Raj, Moses S., Silverman, Jan F, Finley, Gene Grant

“…Abstract only 593 Background: Immunotherapy (IO) in combination with chemoradiotherapy (CRT) in the neoadjuvant treatment for locally advanced rectal…”
Get full text

Mantle Cell Lymphoma Relapsing as Disease of Skin, Orbit and CNS: An Extremely Rare Presentation and a Review of Literature by Shaikh, Hira, Jani, Prashant, Shah, Rupin, Bilimoria, Farshaad, Uchin, Jeffry, Mewawalla, Prerna

“…Mantle cell lymphoma (MCL) is a form of non-Hodgkin's lymphoma originating from mature B cells. The hallmark gene translocation (11:14) results in…”
Get full text

Correction: Mantle Cell Lymphoma Relapsing as Disease of Skin, Orbit and CNS: An Extremely Rare Presentation and a Review of Literature by Shaikh, Hira, Jani, Prashant, Shah, Rupin, Bilimoria, Farshaad, Uchin, Jeffrey, Mewawalla, Prerna

“…[This corrects the article DOI: 10.14740/jh363w.]…”
Get full text

An Unusual Composite Pilomatrix Carcinoma With Intralesional Melanocytes : Differential Diagnosis, Immunohistochemical Evaluation, and Review of the Literature by JANI, Prashant, CHETTY, Runjan, GHAZARIAN, Danny M

“…We report a case of an extremely rare histologic combination of pilomatrix or pilomatrical carcinoma with admixed melanocytes within the same tumor mass…”
Get full text

Risk after local excision alone for DCIS patients by Rakovitch, Eileen, Nofech-Mozes, Sharon, Hanna, Wedad, Baehner, Frederick L., Saskin, Refik, Butler, Steven M., Tuck, Alan, Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A, Bonin, Michel, Chang, Martin, Robertson, Susan, Slodkowska, Elzbieta, Fong, Cindy H, Anderson, Joseph Michael, Jamshidian, Farid, Cherbavaz, Diana B., Shak, Steven, Paszat, Lawrence Frank

“…Abstract only…”
Get full text